Stock Analysis·← Pickers

AHG

Akso Health Group

Akso Health Group (AHG) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 52.6, with 0/3 trend checks passing.

Price
$1.53
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
52.6
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

AHG with MA50 and MA200

2.502.171.831.491.1607/3110/2401/2204/1707/15
AHG2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$1.57-2.71% vs price
MA200
$1.66-7.59% vs price
RSI (14)
52.6Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
$1.21–$1.2617.6% below price · 4 touches
Support Quality
4 touches0.7× zone volume
Chart Summary
Trend summary for AHG

Akso Health Group (AHG) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $1.53, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 2.7% and below the 200-day moving average by 7.6%.

Momentum and stretch context

AHG currently has an RSI reading of 52.6, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

For traders reviewing AHG next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About Akso Health Group

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

Sector
Technology
Industry
Software - Services
CEO
Yilin Wang
Employees
27
Market cap
$144.9M
Beta
-1.00
52-week range
$1.10 – $2.50
Dividend
No
Exchange
NASDAQ
Country
CN
IPO date
3 Nov 2017
ISIN
US98422P1084
CUSIP
98422P108
Website
ahgtop.com
Company profile data from Financial Modeling Prep. AHG listed on NASDAQ.
Share dilution

AHG shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Sept 2018Sept 2025
Shares outstanding (latest)
141.7M
Since Sept 2018
+2518.0%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. AHG28 data points from Sept 2018 to Sept 2025.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about AHG

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.